Depression Clinical Research Trials

Birmingham : The University of Alabama at Birmingham, Office of Psychiatric Research

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Birmingham : The University of Alabama at Birmingham, Office of Psychiatric Research

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Birmingham : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Birmingham :

A Study of Ketamine in Patients With Treatment-resistant Depression

Birmingham :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Birmingham : Birmingham Psychiatry Pharmaceutical Studies, Inc.

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Birmingham :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Birmingham : Birmingham Research Group Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Birmingham : US009

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Birmingham : Birmingham Psychiatry Pharmaceutical Studies, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Birmingham : UAB

Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic Regulation

Birmingham : Forest Investigative Site 021

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Birmingham : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Birmingham : Teva Investigational Site 225

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Dothan : Harmonex

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Dothan : Dothan Behavioral Medicine Clinic

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Dothan : Dothan Behavioral Medicine Clinic

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Dothan : Harmonex

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Tucson : Radiant Research - Tucson

New Clinical Research Study for Depression

Phoenix : Dedicated Clinical Research

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Phoenix : Dedicated Clinical Research

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Phoenix : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Scottsdale : ResearchOne, Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Tucson : Center for Advanced Improvement

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Tucson : University of Arizona Clinical and Translational Science Center (CATS)

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Tucson : University of Arizona College of Medicine Department of Psychiatry

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Tucson : Genova Clinical Research

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Tucson : Center for Advanced Improvement

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Tucson : University of Arizona College of Medicine Department of Psychiatry

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Tucson : University of Arizona Clinical and Translational Science Center

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Tucson : Forest Investigative Site 032

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Tucson :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Tucson :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Little Rock : Arkansas Psychiatric Clinic Clinical Research Trials, P.A.

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Little Rock : Arkansas Psychiatric Clinic Clinical Research Trials, P.A.

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Little Rock :

A Study of Ketamine in Patients With Treatment-resistant Depression

Little Rock : K&S Professional Research Services, LLC

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Little Rock : Forest Investigative Site 029

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Little Rock : Forest Investigative Site 018

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Little Rock : Arkansas Psychiatric Clinic Clinical Research Trials, P.A.

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Little Rock : Site Reference ID/Investigator# 85593

Efficacy and Safety Study of ABT-436 in Major Depressive Disorder

Little Rock : K&S Professional Research Services, LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Little Rock :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Little Rock : Arkansas Psychiatric Clinic Clinical Research Trials, P.A.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Little Rock : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Little Rock : Call for Information (Investigational Site 0424)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)

Little Rock : Arkansas Psychiatric Clinic Clinical Research Trials

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Arcadia : Pacific Clinical Research Medical Group

Depressed? Not Happy With Your Antidepressant?

Arcadia : Pacific Clinical Research Medical Group

Depressed? Sad? Unmotivated?

Cerritos : Comprehensive Clinical Development - Cerritos, CA

Depression ITN# 11336

Colton : SHANTI Clinical Trials

Depression

Encino : Pharmacology Research Institute, Encino

Are you currently taking an antidepressant such as Celexa, Paxil or Zoloft and experiencing sexual side effects?

Encino : Pharmacology Research Institute, Encino

Studies with investigational antidepressant medications for men and women 18 years and older.

Imperial : Sun Valley Research Center

Have you been diagnosed with Depression and your current medication is not working as it should?

Imperial : Sun Valley Research Center

Patients with Major Depressive Disorder

Los Alamitos : Pharmacology Research Institute, Los Alamitos

A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients with Major Depressive Disorder

Los Alamitos : Pharmacology Research Institute, Los Alamitos

Phase 2, Double-Blind, Placebo-Controlled, Randomized Withdrawal, Parallel Efficacy and Safety Study of GLYX-13 in Subjects with Inadequate/Partial Response to Antidepressants During the Current Episode of Major Depressive Disorder

Los Alamitos : Pharmacology Research Institute, Los Alamitos

Studies with investigational antidepressant medications for men and women 18 years and older.

Newport Beach : Pharmacology Research Institute, Newport Beach

A Double-Blind, Placebo-Controlled, Fixed-Dose Study of Vilazodone in Patients with Major Depressive Disorder

Newport Beach : Pharmacology Research Institute, Newport Beach

Are you currently taking an antidepressant such as Celexa, Paxil or Zoloft and experiencing sexual side effects?

Newport Beach : Pharmacology Research Institute, Newport Beach

Studies with investigational antidepressant medications for men and women 18 years and older.

Orange : Pacific Clinical Research Medical Group

Being a Kid is Hard Enough without having to deal with DEPRESSION

Orange : Pacific Clinical Research Medical Group

Depressed? Clinical Research Trial for Depression Now Enrolling in Orange, CA.

Sherman Oaks : Schuster Medical Research Institute

Clinical Research Study of an investigational medication for treatment resistant Major Depressive Disorder

Sherman Oaks : California Neuroscience Research Medical Group, Inc. Updated

Clinical research study of an investigational medication vs. placebo added to a standard antidepressant treatment in persons with Major Depression.

Sherman Oaks : Schuster Medical Research Institute

Do you suffer from Bipolar Depression?

Sherman Oaks : Schuster Medical Research Institute

On An Antidepressant but STILL NOT Feeling Better?

Sherman Oaks : Schuster Medical Research Institute

Research study of an investigational medication for Major Depression Disorder with partial response to antidepressants SSRI

Upland : Pacific Clinical Research Medical Group

Depressed?

Upland : Pacific Clinical Research Medical Group, Upland CA

Depressed? Sad? Clinical Trial for Depression Now Enrolling in Upland, CA

Upland : Pacific Clinical Research Medical Group

Depressed? Clinical Research Trial for Depression Now Enrolling in Upland, CA

Wildomar : Elite Clinical Trials, Inc.

Are you depressed? Do you feel like you just can't get beyond your depression?

Anaheim : South Coast Clinical Trials, Inc

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Anaheim :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Anaheim : South Coast Clinical Trials

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Arcadia : US010

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Arcadia : Pacific Clinical Research Medical Group

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Arcadia : Forest Investigative Site 050

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Beverly Hills :

A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial

Beverly Hills : Forest Investigative Site 030

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Beverly Hills : Forest Investigative Site 030

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Carson : AV Institue, Inc. Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Cerritos :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Cerritos : Forest Investigative Site 018

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Chino : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Chino : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Chino :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Chino : Catalina Research Institute, Llc

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Chino : Catalina Research Institute, Llc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Chino : Forest Investigative Site 012

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Chino : Catalina Research Institute, LLC

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Colton : Shanti Clinical Trials

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Costa Mesa : ATP Clinical Research, Incorporated

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Costa Mesa : ATP Clinical Research, Incorporated

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Costa Mesa : ATP Clinical Research, Inc.

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Costa Mesa : Forest Investigative Site 009

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Costa Mesa :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Costa Mesa :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Costa Mesa : ATP Clinical Research, Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Costa Mesa : Forest Investigative Site 022

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Costa Mesa : Forest Investigative Site 028

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Costa Mesa : Clinical Innovation, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Costa Mesa : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Downey : Diligent Clinical Trials

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Downey : Diligent Clinical Trials

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Encino :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Encino : Pharmacology Research Institute

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Escondido : Synergy Clinical Research Center

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Escondido :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Escondido : Synergy Clinical Reserach Center of Escondido

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Garden Grove :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Garden Grove : Site Reference ID/Investigator# 87228

Efficacy and Safety Study of ABT-436 in Major Depressive Disorder

Garden Grove : Collaborative Neuroscience Network, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Garden Grove : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Garden Grove : Forest Investigative Site 077

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Garden Grove : Call for Information (Investigational Site 0042)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)

Garden Grove : Collaborative Neuroscience Network, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Glendale : Behavioral Research Specialists, LLC

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Glendale : California Clinical Trials Medical Group

A Multiple Ascending Oral Dose Evaluation of the Safety, Tolerability, and Pharmacokinetics of DSP-1053 and Its Metabolites in Healthy Subjects and in Subjects With Major Depressive Disorder

Glendale : Behavioral Research Specialists, LLC

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Glendale : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Glendale : Behavioral Research Specialists, Llc

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Glendale :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Glendale : Behavioral Research Specialists, Llc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Glendale : California Clinical Trials

Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects

Glendale : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Huntington Beach : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Imperial : Sun Valley Research Center

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Imperial : Sun Valley Research Center

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Imperial : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Imperial :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Irvine : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Irvine :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Irvine : University of California, Irvine Child Development Center Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Irvine : Irvine Center for Clinical Research

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

La Habra : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

La Habra : Omega Clinical Trials

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Long Beach : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Long Beach : Veterans Affairs Long Beach Healthcare System

Vilazodone for the Treatment of Posttraumatic Stress Disorder

Los Alamitos : Pharmacology Research Institute

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Los Angeles :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Los Angeles : Forest Investigative Site 017

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Los Angeles : University of California (UCLA) Updated

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Los Angeles : Provate Practice of Andrew Leuchter, MD

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Los Angeles : UCLA Depression Research & Clinic Program

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Los Angeles : UCLA Semel Institute

Vilazodone for Treatment of Geriatric Depression

Mission Viejo : A.D.D. Treatment Center

International Study to Predict Optimised Treatment - in Depression

National City : Synergy Clinical Research Center

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

National City : Synergy Clinical Research Center

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

National City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

National City : US001

Efficacy and Safety of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment

National City : Site Reference ID/Investigator# 87214

Efficacy and Safety Study of ABT-436 in Major Depressive Disorder

National City : US001

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

National City : Forest Investigative Site 019

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Newport Beach : Forest Investigative Site 022

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Newport Beach :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Newport Beach : Pharmacology Research Institute

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Newport Beach : Forest Investigative Site 005

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Norwalk :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Oakland : Site Reference ID/Investigator# 87220

Efficacy and Safety Study of ABT-436 in Major Depressive Disorder

Oakland : Pacific Research Partners, LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Oakland :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Oceanside : Forest Investigative Site 004

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Oceanside :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Oceanside :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Oceanside : North County Clinical Research Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Oceanside : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Oceanside : Forest Investigative Site 039

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Oceanside : Forest Investigative Site 015

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Orange : Pacific Clinical Research Medical Group

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Orange : Pacific Clinical Research Medical Group

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Orange : Pacific Clinical Research Medical Group

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Orange :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Orange : US007

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Orange : Pacific Clinical Research Medical Group

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Palo Alto : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Palo Alto : Stanford -VA Palo Alto Health Care System

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

Palo Alto : Stanford -VA Palo Alto Health Care System

Major Depressive Disorder With Mixed Features - Extension

Paramount :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Paramount :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Pasadena : Pasadena Research Institute, LLC Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Redlands : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Redlands : Anderson Clinical Research

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Redlands : Anderson Clinical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Redlands : Anderson Clinical Research

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Redlands : Forest Investigative Site 008

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Redlands : Call for Information (Investigational Site 0027)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)

Riverside : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Riverside : Forest Investigative Site 027

Safety and Efficacy of Vilazodone in Major Depressive Disorder

San Bernardino : Breakthrough Clinical Trials

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

San Bernardino : BreakThrough Clinical Trials, LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

San Bernardino :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

San Diego : South Bay Research Center

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

San Diego : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

San Diego : Forest Investigative Site 007

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

San Diego : Forest Investigative Site 054

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

San Diego :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

San Diego : Artemis Institute For Clinical Research

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

San Diego : Sharp Mesa Vista Hospital

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

San Diego : Clinical Innovations, Inc. Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

San Diego : Sharp Mesa Vista Hospital Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

San Diego : Affiliated Research Institute Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

San Diego : Pacific Research Network

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

San Diego : California Neuropsychopharmacology Clinical

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

San Diego : Artemis Institute For Clinical Research

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

San Diego : Sharp Mesa Vista Hospital

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

San Diego : Affiliated Research Institute

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

San Diego : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

San Diego : Forest Investigative Site 026

Safety and Efficacy of Vilazodone in Major Depressive Disorder

San Diego : PCSD - Feighner Research

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

San Diego : Artemis Institute for Clinical Research

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

San Diego : UCSD Medical Center

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Santa Ana : Neuropsychiatric Research Center of Orange County

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Santa Ana : Neuropsychiatric Research Center of Orange County

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Santa Ana :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Santa Ana : Neuropsychiatric Research Center Of Orange County

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Santa Ana : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Santa Ana : Forest Investigative Site 015

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Santa Ana : Neuropsychiatric Research Center of Orange County

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Sherman Oaks : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Sherman Oaks : Schuster Medical Research Institute

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Sherman Oaks : California Neuroscience Research Medical Group, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Sherman Oaks : Forest Investigative Site 066

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Sherman Oaks : Call for Information (Investigational Site 0422)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)

Sherman Oaks : California Neuroscience Research Medical Group, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Sherman Oaks : Teva Investigational Site 295

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Stanford : Stanford University

International Study to Predict Optimised Treatment - in Depression

Stanford : Veteran Affairs/Stanford University

International Study to Predict Optimised Treatment - in Depression

Tarzana : Center for Healing the Human Spirit

International Study to Predict Optimised Treatment - in Depression

Temecula : Forest Investigative Site 031

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Temecula : Forest Investigative Site 011

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Temecula : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Temecula : Teva Investigational Site 122

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Torrance :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Torrance : US004

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Upland : Pacific Clinical Research Medical Group

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Victorville : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Wildomar : Elite Clinical Trials, Incorporated

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Wildomar : Elite Clinical Trials, Incorporated

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Wildomar :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Wildomar :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Denver : Radiant Research - Denver

Clinical Research for Depression

Denver : Radiant Research - Denver

Research Study for Depression

Denver : Radiant Research - Denver

Still Depressed?

Aurora : Children's Hospital Colorado

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Aurora : The Children's Hospital

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Centennial :

A Study of Ketamine in Patients With Treatment-resistant Depression

Colorado Springs : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Colorado Springs : MCB Clinical Research Centers

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Colorado Springs :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Denver : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Denver : Forest Investigative Site 048

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Denver : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Denver : Western Affiliated Research Institute

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Denver :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Denver : Western Affiliated Research Institute

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Denver : Radiant Research, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Denver : Western Affiliated Research Institute

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Cromwell : Connecticut Clinical Research

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Cromwell : Connecticut Clinical Research

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Cromwell : Forest Investigative Site 016

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Cromwell : Connecticut Clinical Research

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Farmington : University of Connecticut Health Center

Study of Technology-assisted Treatment of Adolescent Depression

Hamden : Geriatric and Adult Psychiatry, LLC Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Hartford :

A Study of Ketamine in Patients With Treatment-resistant Depression

Hartford : Forest Investigative Site 029

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Hartford : Institute of Living

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Hartford : Hartford Hospital Institute of Living

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

New Britain : The Hospital of Central Connecticut, Psychiatry & Behavioral Health Research

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

New Haven : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Norwalk :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Norwalk :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Norwich :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Norwich : Comprehensive Psychiatric Care

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Wilmington : Christiana Care Health Services

Patient-Centered Depression Care for African Americans

Washington :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Washington :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Washington : US003

Pharmacokinetics and Tolerability of Lu AA21004 in Child and Adolescent Patients With Depressive or Anxiety Disorder

Maitland : Florida Clinical Research Center - Orlando/Maitland

Are you Depressed?

Maitland : Florida Clinical Research Center - Orlando/Maitland

Depression getting you down?

Pinellas Park : Radiant Research - St. Petersburg

Research Opportunity (Heat Patch)

St. Petersburg : Comprehensive Clinical Development - St. Petersburg, FL

Depression ITN# 11980

St. Petersburg : Comprehensive Clinical Development - St. Petersburg, FL

Depression ITN# 12040

St. Petersburg : Comprehensive Clinical Development - St. Petersburg, FL

Depression ITN# 12040

St. Petersburg : Comprehensive Clinical Development - St. Petersburg, FL

Depression ITN# 12040

Bradenton : Site Reference ID/Investigator# 87215

Efficacy and Safety Study of ABT-436 in Major Depressive Disorder

Bradenton : Florida Clinical Research Center, LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Brooksville : Meridien Research

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Brooksville : Meridien Research

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Clearwater : Innovative Research of West Florida, Inc.

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Clearwater : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Coral Gables : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Coral Gables :

A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial

Coral Springs : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Coral Springs :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Coral Springs : CNS Clinical Research Group Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Destin : SJS Clinical Research

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Destin : SJS Clinical Research, Inc.

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Fort Lauderdale : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Fort Lauderdale : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Fort Lauderdale : Forest Investigative Site 007

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Fort Myers : Gulfcoast Clinical Research Center

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Fort Myers : Forest Investigative Site 006

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Fort Myers : Gulfcoast Clinical Research Center

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Gainesville : Sarkis Clinical Trials

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Gainesville : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Gainesville : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Gainesville :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Gainesville : Sarkis Clinical Trials

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Hallandale Beach : Forest Investigative Site 023

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Hallandale Beach : Call for Information (Investigational Site 0036)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)

Hallandale Beach : Forest Investigative Site 004

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Hialeah : Amedica Research Institute, Incorporated

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Hialeah : Amedica Research Institute, Incorporated

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Hollywood : Segal Institute for Clinical Research

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Jacksonville : Clinical Neuroscience Solutions, Inc.

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Jacksonville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Jacksonville : Clinical Neuroscience Solutions, Inc.

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Jacksonville :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Jacksonville : Amit Vijapura

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Jacksonville : Clinical Neuroscience Solutions, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Jacksonville : Amit Vijapura

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Jacksonville : Forest Investigative Site 029

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Jacksonville : Forest Investigative Site 012

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Jacksonville : Clinical Neuroscience Solutions, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Jacksonville : Private Practice - Amit Vijapura MD

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Jacksonville Beach : Forest Investigative Site 008

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Jacksonville Beach : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Jacksonville Beach : Teva Investigational Site 606

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Juno Beach : Advanced Mental Health Care Inc. - Juno Beach Updated

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Kissimmee : Accurate Clinical Trials

Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder

Kissimmee : Forest Investigative Site 012

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Lake City : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Lake City : Forest Investigative Site 063

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Lake City : Psychiatric Associates

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Lauderhill :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Lauderhill :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Lauderhill : Teva Investigational Site 127

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Leesburg : Forest Investigative Site 006

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Leesburg : Compass Research, LLC: North Clinic

Efficacy of Electronic Cognitive Behavioral Therapy Application to Treat Major Depressive Disorder

Leesburg : Forest Investigative Site 015

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Maitland : Florida Clinical Research Center, LLC. Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Maitland : US006

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Melbourne :

A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial

Miami : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Miami : Forest Investigative Site 026

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Miami :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Miami : US003

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Miami : University of Miami

International Study to Predict Optimised Treatment - in Depression

Miami : Miami Jewish Health System

Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder

Miami : Forest Investigative Site 023

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Miami Springs : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Miramar : Comprehensive Neuroscience, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

New Port Richey : Suncoast Clinical Research Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

North Miami : Forest Investigative Site 027

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

North Miami :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

North Miami : Scientific Clinical Research, Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

North Miami : Fideltiy Clinical Research, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

North Miami : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)

Oakland Park :

A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial

Oakland Park : Forest Investigative Site 036

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Orange City :

A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial

Orange City :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Orlando : Ali A. Kashfi, MD

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Orlando : Clinical Neuroscience Solutions Incorporated

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Orlando : Clinical Neuroscience Solutions Incorporated

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Orlando : Ali A. Kashfi, MD

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Orlando :

A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial

Orlando : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Orlando : Forest Investigative Site 051

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Orlando :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Orlando : Clinical Neuroscience Solutions, Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Orlando : Compass Research, LLC Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Orlando :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Orlando : Clinical Neuroscience Solutions, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Orlando : Compass Research, Llc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Orlando : Forest Investigative Site 026

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Orlando : Forest Investigative Site 035

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Orlando : Ali A. Kashfi, MD, PA

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Royal Palm Beach : Advanced Mental Health Care Inc. - Royal Palm Beach Updated

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Sanford :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

South Miami : Forest Investigative Site 044

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

South Miami : Site Reference ID/Investigator# 87225

Efficacy and Safety Study of ABT-436 in Major Depressive Disorder

St. Petersburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

St. Petersburg : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

St. Petersburg : Meridien Research Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

St. Petersburg : Comprehensive NeuroScience, Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

St. Petersburg :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

St. Petersburg : Comprehensive Clinical Development, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Tampa : Meridien Research

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Tampa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Tampa : Stedman Clinical Trials

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Tampa :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Tampa : Stedman Clinical Trials Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

University Park : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)

West Palm Beach :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

West Palm Beach : Janus Center For Psychiatric Research

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

West Palm Beach : Janus Center for Psychiatric Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

West Palm Beach :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

West Palm Beach : Janus Center For Psychiatric Research

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

West Palm Beach : Forest Investigative Site 001

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Winter Haven : Clinical Research of Central Florida

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Winter Park : Kolin Research Group

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Winter Park : Winter Park Memorial Hospital

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Winter Park : Winter Park Memorial Hospital

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Winter Park : Kolin Research Group

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Winter Park : Forest Investigative Site 019

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Winter Park : Kolin Research Group

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Atlanta : Mood and Anxiety Disorders Program of Emory University

Have you been feeling sad or down nearly every day over the past month?

Atlanta : Mood and Anxiety Disorders Program of Emory University

How are you feeling?

Atlanta : Comprehensive Clinical Development - Atlanta, GA New

Still Feeling Depressed? ITN# 11318

Stockbridge : Mood and Anxiety Disorders Program of Emory University

Have you been feeling sad or down nearly every day over the past month?

Atlanta : Atlanta Center for Medical Research

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Atlanta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Atlanta : Atlanta Center for Medical Research

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Atlanta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Atlanta :

A Study of Ketamine in Patients With Treatment-resistant Depression

Atlanta : Atlanta Center for Medical Research

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Atlanta : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Atlanta : Forest Investigative Site 024

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Atlanta : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Atlanta :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Atlanta : Emory University

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Atlanta :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Atlanta : Site Reference ID/Investigator# 85594

Efficacy and Safety Study of ABT-436 in Major Depressive Disorder

Atlanta : Atlanta Institute of Medicine & Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Atlanta : Atlanta Center for Medical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Atlanta : Comprehensive Neuroscience, Inc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Atlanta : Emory University

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Atlanta : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Atlanta : Emory University

Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression

Atlanta : Forest Investigative Site 062

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Atlanta : Forest Investigative Site 005

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Atlanta : Forest Investigative Site 038

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Atlanta : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Atlanta : Teva Investigational Site 205

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Columbus : Medical Research and Health Education Foundation, Inc.

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Decatur : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Marietta : Northwest Behavioral Research Center

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Marietta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Marietta : Northwest Behavioral Research Center/Northwest Behavioral Medicine

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Marietta : Forest Investigative Site 017

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Roswell : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Smyrna : Institute for Behavioral Medicine, LLC

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Smyrna : Institute for Behavioral Medicine, LLC

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Smyrna : Forest Investigative Site 047

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Smyrna :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Smyrna : Carman Research Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Smyrna : Carman Research

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Smyrna : Forest Investigative Site 065

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Smyrna : Call for Information (Investigational Site 0028)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)

Smyrna : Institute for Behavioral Medicine, LLC

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Smyrna : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Chicago : Rush University Medical Center - Treatment Research Center

Do you suffer from Depression?

Chicago : Rush University Medical Center - Treatment Research Center

Preventing the Recurrence of Depression in Bipolar Disorder

Chicago : Chicago Research Center, Inc

This research will evaluate the safety, tolerability and efficacy of an experimental drug, Levomilnacipran, sustained release (SR) compared to placebo (inactive substance) in the potential treatment of depression in people with Major Depressive Disorder.

Skokie : Psychiatric Medicine Associates/John Zajecka, M.D.

Depression Research Study

Skokie : Psychiatric Medicine Associates/John Zajecka, M.D.

Depression Research Study for adults who are currently taking an antidepressant but still experiencing some symptoms of depression

Skokie : Rush University Medical Center - Treatment Research Center

Depression Study. A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo- Controlled, Phase III, Efficacy and Safety Study of 3 Fixed Dose Groups of TC-5214 (S-mecamylamine) as an Adjunct to an Antidepressant in Patients with Major Depressive Disorder Who Exhibit an Inadequate Response to Antidepressant Therapy

Chicago :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Chicago :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Chicago : Rush Medical College

Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression

Chicago : Treatment Research Center, Rush University Medical Center

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Chicago : TMS Specialists Chicago

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Hoffman Estates : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Hoffman Estates : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Hoffman Estates : Forest Investigative Site 013

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Hoffman Estates :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Hoffman Estates : Forest Investigative Site 019

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Hoffman Estates : Alexian Brothers Center for Psychiatric Research

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Joliet : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Joliet :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Libertyville : Capstone Clinical Research

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Libertyville : Capstone Clinical Research

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Libertyville : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Naperville : AMR-Baber Research Inc.

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Naperville : AMR-Baber Research Inc.

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Naperville :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Oak Brook : American Medical Research, Inc. Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Oak Brook :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Oak Brook : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Skokie : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Skokie :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Skokie : Psychiatric Medicine Associates, LLC

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Vernon Hills : Sleep and Behavior Medicine Institute

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Indianapolis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Indianapolis : The Davis Clinic Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Indianapolis :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Indianapolis : Forest Investigative Site 021

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Indianapolis : Forest Investigative Site 024

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Lafayette : Forest Investigative Site 042

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Lafayette : Alpine Clinic

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Lafayette : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Lafayette : Teva Investigational Site 600

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Newburgh : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Newburgh : Pedia Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Terre Haute : Clinco

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Terre Haute : Clinco

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Terre Haute : Clinco

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Valparaiso : Northwest Indiana Center for Clinical Research Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Wichita : Via Christi Research

ARTDeCo: Adding Study Drug to Current Antidepressant Not Adequately Treating Major Depressive Disorder

Overland Park : Psychiatric Associates

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Overland Park : Psychiatric Associates

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Prairie Village : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Prairie Village : Clinical Trials Technology, Inc

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Prairie Village :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Prairie Village : Clinical Trials Technology, Inc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Prairie Village : Forest Investigative Site 074

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Prairie Village : Call for Information (Investigational Site 0041)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)

Prairie Village : Forest Investigative Site 031

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Prairie Village : Clinical Trials Technology, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Prairie Village : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)

Wichita : Heartland Research Associates, LLC

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Wichita : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Wichita : Heartland Research Associates

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Wichita : US004

Pharmacokinetics and Tolerability of Lu AA21004 in Child and Adolescent Patients With Depressive or Anxiety Disorder

Wichita : University of Kansas

Phase 2, Double-Blind, Placebo Controlled, Randomized Withdrawal, Parallel Efficacy and Safety Study of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants During the Current Episode of Major Depressive Disorder

Edgewood : OtriMed Clinical Research

Adult Major Depressive Disorder Clinical Trial

Lexington : Kentucky Medical Research

Depression

Florence : MCM Clinical Research LLC Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Lexington : Central Kentucky Research Associates, Inc.

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Owensboro : Pedia Research, LLC

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Lake Charles : Lake Charles Clinical Trials

Study of Cariprazine in Participants with Bipolar Depression

Lake Charles : Lake Charles Clinical Trials

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Lake Charles : Lake Charles Clinical Trials

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Lake Charles : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Lake Charles :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Lake Charles : Forest Investigative Site 041

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

New Orleans : James G. Barbee, Md, Llc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

New Orleans : Call for Information (Investigational Site 0407)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)

Shreveport : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Shreveport :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Shreveport : Ert

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Shreveport :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Shreveport : Louisiana Clinical Research, LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Shreveport :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Shreveport : J. Gary Booker, Md, Apmc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Shreveport : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Shreveport : Forest Investigative Site 040

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Gaithersburg : Potomac Grove Clinical Research Center

An Investigational Medication for Major Depressive Disorder

Gaithersburg : Potomac Grove Clinical Research Center

Major Depressive Disorder and Sexual Dysfunction

Baltimore : Pharmasite Research Inc

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Baltimore : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Baltimore : Pharmasite Research Inc

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Baltimore : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Baltimore : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Baltimore : Pharmasite Research, Inc. Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Baltimore :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Baltimore : Johns Hopkins University

Lexapro for the Treatment of Traumatic Brain Injury (TBI) Depression & Other Psychiatric Conditions

Baltimore : Johns Hopkins School of Medicine

Patient-Centered Depression Care for African Americans

Baltimore : Sinai Hospital

Patient-Centered Depression Care for African Americans

Baltimore : Johns Hopkins Community Phsyicians

Patient-Centered Depression Care for African Americans

Baltimore : Baltimore Medical Systems, Middlesex Health Center

Patient-Centered Depression Care for African Americans

Baltimore : Call for Information (Investigational Site 0033)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)

Baltimore : Johns Hopkins University Updated

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Baltimore : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Baltimore : Sheppard Pratt Health System

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Gaithersburg : Forest Investigative Site 049

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Gaithersburg :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Gaithersburg : Potomac Grove Clinical Research Center Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Rockville : Neuroscientific Insights

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Rockville :

A Study of Ketamine in Patients With Treatment-resistant Depression

Rockville : Office of Marc Hertzman, MD Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Brighton : Boston Clinical Trials

Do you often feel sad, down and unmotivated? Have you been taking medication for depression but still have symptoms?

Brighton : Boston Clinical Trials

I Feel Blue…

Brighton : Boston Clinical Trials

Stuck with Depression? You are not alone.

Haverhill : ActivMed Practices & Research, Inc.

Are you between the ages of 18 and 65 and suffering from Depression?

Haverhill : ActivMed Practices & Research, Inc.

Are you or a loved one suffering from symptoms of Bipolar Disorder?

Belmont : Mclean Hospital

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Belmont : McLean Hospital - McLean Imaging Center

Functional and Neurochemical Correlates of Treatment Response in Major Depressive Disorder

Belmont : McLean Hospital

Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder (MDD) Partly Responsive to Selective Serotonin Reuptake Inhibitor (SSRI) or Selective Norepinephrine Reuptake Inhibitor (SNRI) Treatment

Belmont : Mclean Hospital

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Boston : Boston Clinical Trials

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Boston :

A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial

Boston : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Boston : Forest Investigative Site 046

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Boston :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Boston : Massachusetts General Hospital

Escitalopram (Lexapro) for the Treatment of Postpartum Depression

Boston : Massachusetts General Hospital

Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and Irritability

Boston : Massachusetts General Hospital - Center for Anxiety and Traumatic Stress Disorders

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

Boston : Massachusetts General Hospital - Center for Anxiety and Traumatic Stress Disorders

Major Depressive Disorder With Mixed Features - Extension

Boston : Forest Investigative Site 003

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Boston : Massachusetts General Hospital- Depression Clinical and Research Program

Transcranial Laser Therapy for Major Depressive Disorder

Cambridge : Cambridge Health Alliance

Ropinirole in the Treatment of Bipolar Depression

Chelsea : Chelsea Counseling Center- North Suffolk Mental Health Association

Transcranial Laser Therapy for Major Depressive Disorder

Haverhill : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Haverhill : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Natick : Forest Investigative Site 045

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Watertown : Adams Clinical Trials, LLC Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Watertown : Teva Investigational Site 603

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Weymouth : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Weymouth :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Weymouth : Forest Investigative Site 013

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Weymouth : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Woburn : Woburn Pediatric Associates

Study of Technology-assisted Treatment of Adolescent Depression

Ann Arbor : Michigan Head Pain and Neurological Institute

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Rochester Hills : Forest Investigative Site 028

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Rochester Hills : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Minneapolis : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Flowood : Precise Research Centers

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Flowood : Precise Research Centers

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Flowood : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Flowood : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Flowood :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Flowood :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Flowood : Forest Investigative Site 039

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Are you down in the dumps with your diabetes?

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Depression Research Study Seeks Volunteers with Heart Failure.

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Pre-diabetes: Are you at risk?

Creve Coeur : Millennium Psychiatric Associates, LLC

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Creve Coeur : Millennium Psychiatric Associates, LLC

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Creve Coeur : Millennium Psychiatric Associate

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Creve Coeur :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Creve Coeur : Forest Investigative Site 026

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Creve Coeur : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Gladstone : Comprehensive Psychiatric Associates

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Kansas City : The Center for Pharmaceutical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

O'Fallon : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

O'Fallon : Psyichatric Care and Research Center

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

St. Charles : Midwest Research Group

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

St. Charles : St. Charles Psychiatric Associates - Midwest Research Group

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

St. Charles : Midwest Chest Consultants

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

St. Charles : St. Charles Psychiatric Associates - Midwest Research Group Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

St. Charles : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)

St. Louis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

St. Louis : Scientella LLC

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

St. Louis : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

St. Louis :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

St. Louis :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

St. Louis : Mercy Health Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

St. Louis :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

St. Louis : St. Louis Clinical Trials

Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder

St. Louis : Mid-America Clinical Research, LLC

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

St. Louis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)

St. Louis : Washington University School of Medicine

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Lincoln : Premier Psychiatric Research Institute, LLC

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Lincoln : Premier Psychiatric Research Institute, LLC

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Lincoln : Premier Psychiatric Group Updated

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Lincoln : Premier Psychiatric Research Institute, LLC.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

North Platte : Heartland Pharma Development

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

North Platte :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Omaha : Quality Clinical Research, Inc.

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Omaha : Creighton University, Department of Psychiatry

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Omaha : University of Nebraska Medical Center

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Las Vegas : Center for Psychiatry and Behavioral Medicine, Incorporated

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Las Vegas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Las Vegas : Center for Psychiatry and Behavioral Medicine, Incorporated

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Las Vegas :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Las Vegas : Forest Investigative Site 037

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Las Vegas : Clinical Research Consortium

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Keene : Family Medicine Clinics, Cheshire Medical Center (DH-Keene)

Enhanced Collaborative Depression Treatment in Primary Care: The RESPECT-D-E Trial

Nashua : Greater Nashua Mental Health Center Updated

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Cherry Hill : Center For Emotional Fitness

DEPRESSION

Cherry Hill : University of Medicine and Dentistry of New Jersey - School of Osteopathic Medicine

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Mount Laurel : CRI Lifetree

Do you or a loved one suffer from Depression?

New Brunswick : UMDNJ-Robert Wood Johnson Medical School

Coping With Depression in Parkinson's Disease

Berlin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Cherry Hill :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Cherry Hill : Forest Investigative Site 061

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Cherry Hill : Forest Investigative Site 023

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Cherry Hill : Center for Emotional Fitness

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Cherry Hill : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Cherry Hill : Center for Mood Disorders and Neuromodulation Therapies, UMDNJ-SOM

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Marlton :

A Study of Ketamine in Patients With Treatment-resistant Depression

Marlton : CRI Lifetree

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Marlton : Site Reference ID/Investigator# 85580

Efficacy and Safety Study of ABT-436 in Major Depressive Disorder

Marlton : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Parsippany : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Princeton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Toms River : Forest Investigative Site 014

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Toms River :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Toms River : Bio Behavioral Health

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Toms River : Bio Behavioral Health

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Toms River : Bio Behavioral Health

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Willingboro : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Willingboro :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Willingboro : Forest Investigative Site 038

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Willingboro : Forest Investigative Site 014

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Willingboro : CRI Worldwide LLC

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Albuquerque : Forest Investigative Site 058

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Albuquerque :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Albuquerque : Albuquerque Neuroscience, Inc.

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Albuquerque : Albuquerque Neuroscience, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Albuquerque : Forest Investigative Site 030

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Albuquerque : Forest Investigative Site 006

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Albuquerque : Albuquerque Neuroscience, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Albuquerque : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)

Bronx : Biomedical Research Alliance of New York

Major Depressive Disorder

New York : Clinilabs, Inc.

Are anti-depression medications just not working for you? (New York, NY)

New York : Medical & Behavioral Health Research, PC

Bipolar Depression

New York : Medical & Behavioral Health Research, PC

Bipolar Depression Research Study

New York : Medical & Behavioral Health Research, PC

Depressed?

New York : Medical & Behavioral Health Research, PC

DEPRESSED? 18-65 YEARS OLD?

New York : Clinilabs, Inc.

Feeling Depressed?

New York : Clinilabs, Inc.

Have you been diagnosed with major depression? Do you continue to have symptoms despite medications?

New York : Clinilabs, Inc.

Have you been diagnosed with major depression? Do you continue to have symptoms despite medications?

New York : Biomedical Research Alliance of New York

Major Depressive Disorder

Bronx : Montefiore Medical Center

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Brooklyn : Social Psychiatry Research Institute

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Brooklyn : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Brooklyn : Forest Investigative Site 028

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Brooklyn : Site Reference ID/Investigator# 87227

Efficacy and Safety Study of ABT-436 in Major Depressive Disorder

Brooklyn : Brooklyn Medical Institute

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Brooklyn : US014

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Brooklyn : Social Psychiatry Research Institute

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Brooklyn : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Brooklyn : Forest Investigative Site 076

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Brooklyn : Forest Investigative Site 003

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Brooklyn : Teva Investigational Site 207

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Buffalo :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Cedarhurst :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Cedarhurst : Neurobehavioral Research, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Cedarhurst : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Fresh Meadows : Comprehensive Clinical Development, Inc

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Fresh Meadows : Comprehensive Clinical Development, Inc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Fresh Meadows : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Glen Oaks : The Zucker Hillside Hospital

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Jamaica : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Mount Kisco : Bioscience Research, LLC.

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Mount Kisco : Bioscience Research, LLC.

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Mount Kisco : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Mount Kisco : Bioscience Research, Llc

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Mount Kisco : Bioscience Research, LLC Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Mount Kisco : Bioscience Research, Llc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Mount Kisco : Forest Investigative Site 037

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

New York : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

New York : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

New York :

A Study of Ketamine in Patients With Treatment-resistant Depression

New York : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

New York : Forest Investigative Site 016

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

New York : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

New York : New York State Psychiatric Institute/Columbus Circle Midtown

Desvenlafaxine vs. Placebo Treatment of Chronic Depression

New York : Depression Evaluation Service (DES), New York State Psychiatric Institute, Columbia University Department of Psychiatry

Desvenlafaxine vs. Placebo Treatment of Chronic Depression

New York : Village Clinical Research, Inc.

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

New York :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

New York : Site Reference ID/Investigator# 87223

Efficacy and Safety Study of ABT-436 in Major Depressive Disorder

New York : Fieve Clinical Research Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

New York : Medical & Behavioral Health Research, PC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

New York :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

New York : US011

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

New York : US013

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

New York : Village Clinical Research, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

New York : New York State Psychiatric Institute

NMDA Antagonists in Bipolar Depression

New York : New York State Psychiatric Institute, 1051 Riverside Drive

Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression

New York : Forest Investigative Site 067

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

New York : Call for Information (Investigational Site 0039)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)

New York : Forest Investigative Site 009

Safety and Efficacy of Vilazodone in Major Depressive Disorder

New York : Spectrum Neuroscience Updated

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

New York : Columbia University / New York State Psychiatric Institute Updated

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

New York : Mount Sinai Hospital Updated

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

New York : Forest Investigative Site 025

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

New York : Clinlabs, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

New York : Mount Sinai School of Medicine

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

New York : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

New York : Teva Investigational Site 202

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

New York : Mount Sinai School of Medicine

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Rochester : Finger Lakes Clinical Research

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Rochester : Finger Lakes Clinical Research

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Rochester : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Rochester :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Rochester : Finger Lakes Clinical Research

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Staten Island : Forest Investigative Site 025

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Staten Island :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Staten Island : Richmond Behavioral Associates Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Staten Island :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Staten Island : Call for Information (Investigational Site 0411)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)

Staten Island : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Staten Island : Teva Investigational Site 411

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Staten Island : Teva Investigational Site 110

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Stony Brook : Stony Brook University Medical Center

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Stony Brook : Stony Brook University Medical Center

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

West Seneca : Private Practice - Daniel I. Rifkin MD PC

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

White Plains : Weill Cornell Medical College

International Study to Predict Optimised Treatment - in Depression

White Plains : Weill Cornell Medical College-Westchester Division

Treatment Response of Geriatric Depression

Charlotte : Carolinas Healthcare System

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Durham : Forest Investigative Site 050

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Durham : Triangle Neuropsychiatry Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Durham : Psychiatry and Behavioral Sciences, Duke

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

Durham : Psychiatry and Behavioral Sciences, Duke

Major Depressive Disorder With Mixed Features - Extension

Durham : Forest Investigative Site 014

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Durham : Duke Medical Center Department of Psychiatry & Behavioral Sciences Updated

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Durham : Duke University Brain Stimulation and Neurophysiology Center

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Hickory : Clinical Trials of America, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Hope Mills : Inquest Clinical Group/ Global Research Associates

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Raleigh :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Raleigh : Rcihard H. Weisler, MD, PA & Associates Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Raleigh : Richard H. Weisler, Md, Pa & Assoc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Raleigh : Call for Information (Investigational Site 0052)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)

Raleigh : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Winston-salem : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Cincinnati : Community Research

Feeling Depressed?

Cincinnati : Community Research

Not seeing the results you want from your antidepressant?

Avon lake :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Beachwood : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Beachwood : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Beachwood : Northcoast Clinical Trials, Inc

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Beachwood :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Beachwood : Northcoast Clinical Trials, Inc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Beachwood : Call for Information (Investigational Site 0414)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)

Beachwood : North Coast Clinical Trials, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Canton : Neuro-Behvioral Clinical Research, Inc.

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Canton : Neuro-Behavioral Clinical Research, Inc

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Canton : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Canton : Forest Investigative Site 047

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Canton : Forest Investigative Site 036

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Cincinnati : University of Cincinnati

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Cincinnati : Cincinnati Children's Hospital Medical Center

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Cincinnati : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Cincinnati : Forest Investigative Site 011

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Cincinnati : Forest Investigative Site 015

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Cincinnati : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Cincinnati :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Cincinnati : Patient Priority Clinical Sites, Llc

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Cincinnati : Community Research Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Cincinnati : Patient Priority Clinical Sites, Llc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Cincinnati : US002

Pharmacokinetics and Tolerability of Lu AA21004 in Child and Adolescent Patients With Depressive or Anxiety Disorder

Cincinnati : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Cincinnati : Teva Investigational Site 610

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Cleveland : Discovery and Wellness Center for Children/University Hospitals Case Medical Center

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Cleveland : Discovery and Wellness Center for Children/University Hospitals Case Medical Center

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Cleveland : University Hospitals Case Medical Center

Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance

Columbus : Radiant Research, Inc.

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Columbus : Forest Investigative Site 055

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Columbus : Ohio State University

International Study to Predict Optimised Treatment - in Depression

Columbus : Ohio State University, Dept. of Psychiatry

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Columbus : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Dayton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Dayton : Midwest Clinical Research Center

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Dayton :

A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial

Dayton : Midwest Clinical Research Center

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Dayton : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Dayton :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Dayton :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Dayton : Site Reference ID/Investigator# 87217

Efficacy and Safety Study of ABT-436 in Major Depressive Disorder

Dayton : Midwest Clinical Research Center

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Dayton : Midwest Clinical Research Center

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Dayton : Forest Investigative Site 021

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Dayton : Forest Investigative Site 008

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Garfield Heights :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Mason : Lindner Center of HOPE

Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression

Mason : Lindner Center of HOPE Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Mason : Lindner Center of HOP

Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression

Middleburg Heights : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Middleburg Heights : North Star Medical Research, LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Toledo :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Toledo :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Toledo : Neurology & Neuroscience Center Of Ohio

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Toledo : Teva Investigational Site 615

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Enid : Cutting Edge Research of Enid

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Oklahoma City : IPS Research Company

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Oklahoma City : Cutting Edge Research Group

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Oklahoma City : IPS Research Company

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Oklahoma City : Cutting Edge Research of Enid

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Oklahoma City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Oklahoma City : Oklahoma Clinical Research Center

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Oklahoma City : Forest Investigative Site 035

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Oklahoma City :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Oklahoma City :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Oklahoma City : Sooner Clinical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Oklahoma City : SP Research, PLLC Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Oklahoma City :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Oklahoma City : Ips Research Company

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Oklahoma City : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Oklahoma City : Forest Investigative Site 025

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Oklahoma City : Forest Investigative Site 024

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Oklahoma City : IPS Research Company

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Oklahoma City : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Oklahoma City : Teva Investigational Site 401

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Oklahoma City : Teva Investigational Site 609

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Oklahoma City : Teva Investigational Site 616

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Tulsa : Tulsa Clinical Research, Llc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Portland : Summit Research Network (Oregon), Inc.

Depression Research Study

Medford : Sunstone Medical Research, LLC

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Portland : Summit Research Network (Oregon), Incorporated

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Portland : Summit Research Network (Oregon), Incorporated

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Portland : Forest Investigative Site 003

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Portland : Oregon Health & Science University

Circadian Effects of Escitalopram

Portland :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Portland :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Portland : Site Reference ID/Investigator# 87226

Efficacy and Safety Study of ABT-436 in Major Depressive Disorder

Portland : Summit Research Network (Oregon) Inc. Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Portland : US012

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Portland : Summit Research Network (Oregon) Inc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Portland : Forest Investigative Site 022

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Portland : Call for Information (Investigational Site 0040)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)

Portland : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)

Portland : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Salem : Oregon Center For Clinical Investigations, Inc (Occi, Inc)

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Salem : Forest Investigative Site 027

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Salem : Forest Investigative Site 042

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Salem :

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Media : Suburban Research Associates

Are you suffering from depression symptoms?

Media : Suburban Research Associates

Do you suffer from Depression & Pain?

Allentown : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Allentown :

A Study of Ketamine in Patients With Treatment-resistant Depression

Allentown : Lehigh Center for Clinical Research

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Allentown : Forest Investigative Site 052

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Allentown :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Allentown :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Allentown : Lehigh Center for Clinical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Allentown :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Allentown : Forest Investigative Site 009

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Allentown : Teva Investigational Site 406

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Chalfont : Genomind, LLC Updated

An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay

Media : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Media : Suburban Research Associates

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Media :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Media : Suburban Research Associates Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Media : Suburban Research Associates

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Media : Forest Investigative Site 010

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Norristown : Keystone Clinical Studies, Llc

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Norristown :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Norristown : Keystone Clinical Studies, Llc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Norristown : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Philadelphia : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Philadelphia : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Philadelphia : Thomas Jefferson University Updated

Does Vilazodone Help With Antidepressant-associated Sexual Dysfunction?

Philadelphia : University of Pennsylvania Updated

Does Vilazodone Help With Antidepressant-associated Sexual Dysfunction?

Philadelphia :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Philadelphia : Site Reference ID/Investigator# 87221

Efficacy and Safety Study of ABT-436 in Major Depressive Disorder

Philadelphia : CRI Worldwide LLC Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Philadelphia : Belmont Center for Comprehensive Treatment

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Philadelphia :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Philadelphia : University Of Pennsylvania

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Philadelphia : Thomas Jefferson University

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Philadelphia : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Philadelphia : CRI Lifetree- Philadelphia Research Center

Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder

Philadelphia : Forest Investigative Site 025

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Philadelphia : Thomas Jefferson University

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Philadelphia : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Philadelphia : University of Pennsylvania

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Pittsburgh : University of Pittsburgh Medical Center (UPMC)

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Pittsburgh : Ert

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Pittsburgh : Northwest Clinical Research Center

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Pittsburgh : Neuropsychiatric Research Center Of Orange County

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Pittsburgh : University of Pittsburgh School of Medicine Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Pittsburgh : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Pittsburgh : Mood Disorders Treatment Research Program University of Pittsburgh-Western Psychiatric Institute and Clinic

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

West Chester : University Services

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Wyomissing : Behavioral Medicine Center

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Wyomissing : Clinical Research Center of Reading, LLP

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Lincoln : Lincoln Research - Rhode Island

Announcing a medical research study for adults with DEPRESSION and FATIGUE?

Lincoln : Lincoln Research - Rhode Island

Depressed...? Approximately one in 10 people suffer from depression...you are not alone.

Lincoln : Lincoln Research - Rhode Island

Do you feel Depressed? Announcing a medical research study for people with depression.

Lincoln : Lincoln Research - Rhode Island

Is the burden of Depression weighing you down...despite medication?

Lincoln : Lincoln Research - Rhode Island

Suffering from bipolar depression and are depressed and on medication?

East Greenwich : Costal Medical

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

East Providence : Rhode Island Mood & Memory Research Institute Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Lincoln : Forest Investigative Site 059

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Lincoln : Lincoln Research

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Lincoln :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Lincoln : Lincoln Research

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Lincoln : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Providence : Butler Hospital Mood Disorders Research Program, Brown Department of Psychiatry and Human Behavior

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Warwick : Omega Medical Research

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Greer : Radiant Research - Greer

Clinical Research Study for Depression

Mt. Pleasant : Coastal Carolina Research Center

Volunteers who suffer from Fibromyalgia pain and also Depression are needed for a new clinical research study.

Charleston :

A Study of Ketamine in Patients With Treatment-resistant Depression

Charleston :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Charleston : Medical Uni. Of South Carolina (MUSC) Updated

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Charleston : MUSC Institute of Psychiatry, Brain Stimulation Lab

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Columbia : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Columbia :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Columbia : Carolina Clinical Research Services

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Columbia : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Mount Pleasant : Coastal Carolina Research Center

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

North Charleston : Medical University South Carolina Anxiety Disorder Program

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Nashville : Clinical Research Associates

Major Depression

Franklin : Psychiatric Consultants, PC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Franklin :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Franklin : Psychiatric Consultants, Pc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Memphis : Research Strategies of Memphis, LLC

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Memphis : Clinical Neuroscience Solutions, Incorporated

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Memphis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Memphis : Clinical Neuroscience Solutions, Incorporated

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Memphis : Research Strategies of Memphis, LLC

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Memphis :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Memphis : Research Strategies of Memphis, LLC

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Memphis : Clinical Neuroscience Solutions, Inc. Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Memphis :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Memphis : Clinical Neuroscience Solutions, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Memphis : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Memphis : Forest Investigative Site 048

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Memphis : Forest Investigative Site 019

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Memphis : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Nashville : Clinical Research Associates Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Nashville : Centerstone

Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1)

Dallas : Research Across America

Major Depression

Houston : Bayou City Research Corporation

Still Depressed?

San Antonio : Croft Group Research Center

Are you DEPRESSED?

San Antonio : Croft Group Research Center

Are you taking an antidepressant but still depressed?

San Antonio : Radiant Research - San Antonio

Clinical Research for Depression

San Antonio : Croft Group Research Center

Have you had several depressive episodes?

San Antonio : Radiant Research - San Antonio

Research Study for Depression

Austin : FutureSearch Clinical Trials, L.P.

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Austin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Austin : FutureSearch Trials of Neurology

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Austin : FutureSearch Clinical Trials, L.P.

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Austin :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Austin : Future Search Trials

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Austin : Site Reference ID/Investigator# 87219

Efficacy and Safety Study of ABT-436 in Major Depressive Disorder

Austin : FutureSearch Clinical Trials, LP Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Austin : Community Clinical Research, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Austin : Forest Investigative Site 024

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Austin : Senior Adults Specialty Research Updated

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Austin : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Dallas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Dallas :

A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial

Dallas :

A Study of Ketamine in Patients With Treatment-resistant Depression

Dallas : University of Texas Southwestern Medical Center

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Dallas : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Dallas : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Dallas :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Dallas : Futuresearch Trials Of Dallas

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Dallas : Site Reference ID/Investigator# 87216

Efficacy and Safety Study of ABT-436 in Major Depressive Disorder

Dallas : KRK Medical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Dallas : Future Search Trials of Dallas, LP

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Dallas :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Dallas : Futuresearch Trials Of Dallas

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Dallas : Dept. of Psychiatry, UT Southwestern Medical Center

Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose

Dallas : Dept. of Psychiatry, UT Southwestern Medical Center

Major Depressive Disorder With Mixed Features - Extension

Dallas : Forest Investigative Site 020

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Dallas : Forest Investigative Site 023

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Dallas : UT Southwestern Medical Center at Dallas Updated

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Dallas : Forest Investigative Site 007

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Dallas : Pillar Clinical Research, LLC

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Dallas : UT Southwestern Medical Center

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Desoto : Insite Clinical Research

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Desoto : Insite Clinical Research

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Desoto : Teva Investigational Site 403

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Friendswood : Bay Area Clinical Services

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Friendswood : Teva Investigational Site 612

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Houston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Houston : Clinical Trial Network

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Houston : Claghorn-Lesem Research Clinic

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Houston : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Houston : Forest Investigative Site 005

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Houston : Ben Taub General Hospital

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Houston :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Houston : Site Reference ID/Investigator# 87933

Efficacy and Safety Study of ABT-436 in Major Depressive Disorder

Houston :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Houston : Red Oak Psychiatry Associates, Pa

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Houston : Ben Taub General Hospital

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Houston : Ut Health-Houston

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Houston : Forest Investigative Site 070

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Houston : Call for Information (Investigational Site 0031)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)

Houston : Forest Investigative Site 011

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Houston : Forest Investigative Site 027

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Houston : Forest Investigative Site 016

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Houston : Houston Clinical Trials, LLC

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Houston : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Lake Jackson : R/D Clinical Research

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder

Plano : Forest Investigative Site 010

Safety and Efficacy of Vilazodone in Major Depressive Disorder

San Antonio : Univ of Texas Helath Science Center at San Antonio

12- Week Open Label Treatment of Refractory Bipolar Depression

San Antonio : Clinical Trials of Texas, Inc.

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

San Antonio : Clinical Trials of Texas

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

San Antonio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

San Antonio : Clinical Trials of Texas, Inc.

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

San Antonio : Clinical Trials of Texas, Inc

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

San Antonio : Clinical Trials of Texas, Inc.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

San Antonio : Forest Investigative Site 080

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

San Antonio : Forest Investigative Site 002

Safety and Efficacy of Vilazodone in Major Depressive Disorder

San Antonio : Forest Investigative Site 020

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

The Woodlands :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Wharton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Wharton : Wharton Research Center, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Wichita Falls : Grayline Clinical Drug Trials

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Wichita Falls : Grayline Clinical Drug Trials

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Wichita Falls : Grayline Clinical Drug Trials

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Wichita Falls : Grayline Clinical Drug Trials

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Wichita Falls : Grayline Clinical Drug Trials

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Wichita Falls : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Murray : Radiant Research - Salt Lake City

Clinical Research Study for Depression

Murray : Radiant Research - Salt Lake City

Depression Research Study

Murray : Radiant Research - Salt Lake City

Research Study for Depressiondep

Salt Lake CIty : Lifetree Clinical Research

Depression

Salt Lake CIty : Lifetree Clinical Research

Depression

Salt Lake CIty : Lifetree Clinical Research

Depression

Salt Lake City : CRI Lifetree

This study is designed to evaluate the efficacy, safety, and tolerability of cariprazine relative to placebo for the treatment of major depressive disorder as an adjunct to ADT

Salt Lake City : CRI Lifetree

To compare the change from baseline (Week 7 in Phase B) to endpoint (Week 13 in Phase C) in MADRS score of 2 fixed-doses of BMS-820836 (1 and 2 mg/day) versus continuation of the antidepressant treatment to which inadequate response has been prospectively demonstrated in subjects with TRD.

Salt Lake City : CRI Lifetree

To evaluate the efficacy of 6 weeks treatment of RO4995819 versus placebo as adjunctive therapy in patients with MDD having inadequate response to ongoing antidepressant treatment based on mean change in Montgomery Asberg Depression Rating Scale (MADRS) scores from baseline to end of treatment.

Salt Lake City : CRI Lifetree

To evaluate the efficacy of 6 weeks treatment of RO4995819 versus placebo as adjunctive therapy in patients with MDD having inadequate response to ongoing antidepressant treatment based on mean change in Montgomery Asberg Depression Rating Scale (MADRS) scores from baseline to end of treatment.

Salt Lake City : CRI Lifetree

To evaluate the efficacy of treatment with flexible doses of Lu AA21004 (10 or 20 mg QD) versus placebo on cognitive dysfunction in patients with MDD

Salt Lake City : CRI Lifetree

To evaluate the mean difference in Hamilton Depression Rating Scale 17 (HDRS-17) score for the combined GLYX 13 group mean change versus the placebo group mean change at the end of a 6 week randomized withdrawal phase (predose baseline score - score at end of randomized withdrawal period).

Clinton : Ericksen Research and Development Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Clinton : Ericksen Research And Development

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Clinton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)

Murray : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Murray :

A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial

Murray : Clinical Methods Llc

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Murray : Radiant Research, Inc.

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Murray : Call for Information (Investigational Site 0406)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)

Orem :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Salt Lake City : Lifetree Clinical Research, LC

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Salt Lake City : Fatigue Consultation Clinic

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Salt Lake City : Lifetree Clinical Research

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Salt Lake City : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Salt Lake City : University of Utah

Creatine Treatment for Female Adolescents With Depression Who Are Non-Responders to Fluoxetine or Escitalopram

Salt Lake City : Site Reference ID/Investigator# 88874

Efficacy and Safety Study of ABT-436 in Major Depressive Disorder

Salt Lake City :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Salt Lake City : Clinical Methods Llc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Salt Lake City : Psychiatric And Behavioral Solutions

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Salt Lake City : Forest Investigative Site 028

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Woodstock : Neuropsychiatric Associates

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Woodstock : Neuropsychiatric Associates

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Charlottesville : Charlottesville Medical Research

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Charlottesville : Forest Investigative Site 041

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Charlottesville : University of Virginia Updated

Does Vilazodone Help With Antidepressant-associated Sexual Dysfunction?

Charlottesville :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Herndon : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Richmond : Alliance Research Group

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Richmond : Virginia Treatment Center for Children

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Richmond : Virginia Commonwealth University

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Richmond : Virginia Treatment Center for Children

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Richmond : Virginia Commonwealth University

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Richmond : Alliance Research Group

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Richmond :

A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial

Richmond : Forest Investigative Site 031

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Richmond : Alliance Research Group

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Roanoke : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Roanoke : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Seattle : Summit Research Network (Seattle) LLC

Depression Research Study

Bellevue : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Bellevue : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Bellevue : Northwest Clinical Research Center

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Bellevue : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Kirkland : Eastside Therapeutic Resource

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Kirkland : Eastside Therapeutic Resource

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Kirkland :

A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial

Kirkland :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Kirkland : Forest Investigative Site 034

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Kirkland : Call for Information (Investigational Site 0415)

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)

Kirkland : Teva Investigational Site 613

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Richland : Scientella, LLC.

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Seattle : Summit Research Network (Seattle) LLC

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Seattle : Summit Research Network (Seattle) LLC

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Seattle :

A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial

Seattle : Forest Investigative Site 043

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Seattle :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Seattle : Summit Research Network (Seattle) Llc

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Seattle :

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Seattle : Site Reference ID/Investigator# 88876

Efficacy and Safety Study of ABT-436 in Major Depressive Disorder

Seattle : Summit Research Network (Seattle) LLC Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Seattle :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Seattle : Summit Research Network (Seattle) Llc

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Seattle : Forest Investigative Site 032

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Spokane : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Spokane : Teva Investigational Site 605

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Brown Deer :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Brown Deer : Northbrooke Research Center

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Brown Deer : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Middleton : Dean Foundation For Health Research & Education

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Middleton : Dean Foundation For Health Research & Education

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Middleton : Dean Foundation for Health, Research and Education, Inc.

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Milwaukee : Rogers Center for Research and Training, Incorporated

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Milwaukee : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Milwaukee : Rogers Center for Research and Training, Incorporated

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Milwaukee : Forest Investigative Site 056

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Milwaukee :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Waukesha : Forest Investigative Site 057

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Waukesha :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Waukesha : Independent Psychiatric Consultants, Sc, Dba, Ipc Research

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Waukesha : Independent Psychiatric Consultants, SC, dba, IPC Research

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Buenos Aires : Instituto Nacional de Psicopatologia

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Buenos Aires : Cervino

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Buenos Aires : Teva Investigational Site 134

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Buenos Aires : Teva Investigational Site 136

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Caba : Local Institution

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Caba : BA Psychiatric Research Center

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Caba : Centro Medico de Medicina Familiar Mind Out Research

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Cordoba : Local Institution

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Cordoba : Instituto Medico SAMIC

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

La Plata : Local Institution

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Mendoza : Local Institution

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Adelaide : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Brisbane : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Heidelberg : AU004

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Heidelberg : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Melbourne : Swinburne University

International Study to Predict Optimised Treatment - in Depression

Melbourne : The Alfred Hospital

International Study to Predict Optimised Treatment - in Depression

Melbourne : Monash Alfred Psychiatry Research Centre

Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression

Nedlands : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Sydney : The University of New South Wales/ Black Dog Institute

A Study of Omega-3 as a Treatment for Major Depression

Sydney : The University of New South Wales/Black Dog Institute

A Study of Omega-3 as an Augmentor of Antidepressant Treatment for Major Depression

Westmead : Brain Dynamics Centre

International Study to Predict Optimised Treatment - in Depression

Innsbruck : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Wien : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Wien : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Dave :

A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression

Duffel :

Exploratory Study on the Mood and Cytokine Levels in Female Healthy Participants and Major Depressive Disorder Patients

Gent :

A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression

Kortenberg :

A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression

Lede :

A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression

Leuven :

Exploratory Study on the Mood and Cytokine Levels in Female Healthy Participants and Major Depressive Disorder Patients

Sint Niklaas : Dr Lieven De Weirdt

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Rio de Janeiro : Teva Investigational Site 624

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Bourgas :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Kazanlak :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Kazanlak : Forest Investigative Site 307

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Kazanlak : Teva Investigational Site 148

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Novi Iskar :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Pazardjik : Teva Investigational Site 853

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Pleven : Forest Investigative Site 302

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Pleven : Teva Investigational Site 852

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Plovdiv : Forest Investigative Site 301

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Rousse :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Ruse : Teva Investigational Site 370

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Sofia :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Sofia : Forest Investigative Site 306

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Sofia : Forest Investigative Site 305

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Sofia : Teva Investigational Site 854

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Sofia : Teva Investigational Site 247

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Sofia : Teva Investigational Site 855

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Tzerova Koria :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Varna :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Varna : Teva Investigational Site 856

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Varna : Teva Investigational Site 851

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Brampton : Aggarwal & Associates Ltd. Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Burlington :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Burlington : Depression, Mood Disorders and Schizophrenia Treatment Centre Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Chatham : Chatham-Kent Clinical Trials Research Center Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Chatham : CA008

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Chatham : Forest Investigative Site 101

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Gatineau : Pierre-Janet Hospital Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Hamilton : Women's Health Concerns Clinic

Desvenlafaxine Succinate (DVS) for Major Depressive Disorder (MDD) in Midlife Men and Women

Hamilton : Women's Health Concerns Clinic

Duloxetine for Major Depression in Peri-/Postmenopausal Women

Hamilton : St. Joseph's Healthcare, Centre for Mountain Health Services

Longitudinal Study of People Presenting for First Treatment of a Mood Disorder

Hamilton : MacAnxiety Research Centre

Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders

Kelowna :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Kingston : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Kingston :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Kirkland : Merck Frosst Canada

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)

London : Regional Mental Health Care

Aripiprazole and Resistant Postpartum Depression

Medicine Hat :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Mississauga :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Mississauga : Medical Research Associates Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Mississauga : Anxiety and Mood Disorder Center Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Montreal : Centre de Recherche Fernand-Seguin

Effect of Antidepressants on White Matter Structure

Montreal : Local Institution

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Montreal : l'Hopital Louis H. Lafontaine Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Montreal : CA001

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Montreal : Centre de Recherche Fernand Seguin

Inflammatory Markers and Cognitive Function in Major Depression

Montreal : Immunodeficiency Service Montreal Chest Institute McGill University Health Centre

Trial of Citalopram for the Prevention of Depression

Montréal : Douglas Mental Health University Institute

Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study

Oakville : A.K. Karan Holdings Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Oakville : CA007

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Ottawa : Local Institution

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Ottowa : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Parry Sound : International Sleep Clinic, West Parry Sound Health Centre Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Penticton : Dr. Alexander McIntyre Inc.

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Penticton :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Penticton : Dr. Alexander McIntyre Inc Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Penticton : Forest Investigative Site 103

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Pointe-Claire : Kells Medical Research Group Inc. Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Quebec : ALPHA Recherche Clinique Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Sherbrooke : Diex Research Sherbrooke Inc.

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Sherbrooke : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Sherbrooke : Q&T Research Sherbrooke Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Sydney :

Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder

Thornhill : Canadian Centre for Clinical Trials

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Toronto : Toronto General Hospital

A Clinical Evaluation of Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression

Toronto : Local Institution

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Toronto : START Clinic for Mood and Anxiety Disorders Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Toronto : Manna Research Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Toronto : Sleep & Alertness Clinic (Sleep & Alertness Research, Inc.) Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Toronto : Univ Health Network, Toronto Western Hospital Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Toronto : CA002

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Toronto : Center for Addiction and Mental Health (CAMH) Updated

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Toronto : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Vancouver : Local Institution

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Vancouver : CA006

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Vancouver : University of British Columbia, Department of Psychiatry

Neurocognition and Work Productivity in Major Depressive Disorder (MDD)

Vancouver : Institute of Mental Health, University of British Columbia

What is the Antidepressant Mechanism of Action of Quetiapine in Bipolar Depression?

Verdun : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Windsor : Windsor Regional Hospital-Tayfour Campus Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Antofagasta : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Antofagasta : Psocomed Estudios Medicos

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Coquimbo : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Las Condes : Especialidades Medicas L y S

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Las Condes : Centro de Estudios y Tratemiento de Enfermedades Psiquiatricas

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Providencia : Centro de Estudios Clinicos

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Providencia : Biomedica Research Group

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

San Bernardo : Unidad de Salud Mental y Psiquietriea Hospital y CRS El Pino

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

San Miguel : Hospital Barros Luco Trudsau

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Santiago : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Santiago : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Baoding : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression

Baoding : CN005

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Beijing : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression

Beijing : CN004

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Beijing : CN006

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Beijing : CN001

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Changsha : The Second Xiangya Hospital of Central South University

A Clinical Study of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression

Changsha : CN003

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Chengdu : CN013

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Guang Zhou : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression

Guang Zhou : CN011

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Hangzhou : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression

Kunming : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression

Kunming : CN002

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Nanjing : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression

Shanghai : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression

Shanghai : CN012

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Taiyuan : CN014

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Tianjin : CN007

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Xi'An : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression

Xi'an : CN008

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Xi'an : CN009

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Xi'an : CN015

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Rab : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Rijeka : Teva Investigational Site 635

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Split : Teva Investigational Site 631

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Zagreb : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Zagreb : Psychiatric Clinic Vrapoe Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Zagreb : Poliklinika Neuron Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Zagreb : Teva Investigational Site 633

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Zagreb : Teva Investigational Site 634

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Brno : Psychiatricka ambulance

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Brno : Saint Anne s.r.o.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Horovice : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Horovice : Medicana s.r.o.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Hostivice : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Kladno : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Kutna Hora : Psychiatrie s.r.o.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Litomerice : Bialbi s.r.o.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Olomouc : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Prague : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Prague 10 : Clintrial s.r.o.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Prague 5 : Psychiatry Trial s.r.o.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Prague 6 : Prague Medical Services s.r.o.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Ricany : Ricany s.r.o.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Strakonice : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Usti Nad Labem : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Roskilde : The day clinic for treatment of non-psychotic disorders (Roskilde Psychiatry)

Mindfulness-based Behavioural Therapy (MIBT) Versus Psychodynamic Therapy for Patients With Major Depressive Disorder in Psychotherapeutic Day Treatment. A Randomised Clinical Pilot Trial

Parnu : Parnu Hospital, Psychiatric Clinic

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Tallinn : Marienthal Psychiatry and Psychology Center

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Tallinn : North Estonia Medical Centre Foundation Psychiatry Clinic

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Tallinn : Forest Investigative Site 203

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Tallinn : Forest Investigative Site 205

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Tallinn : Forest Investigative Site 201

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Tallinn : Forest Investigative Site 206

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Tartu : Jaanson & Laane OU

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Tartu : Tartu University Hospital Psychiatric Clinic

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Tartu : Forest Investigative Site 207

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Tartu : Forest Investigative Site 208

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Tartu : Forest Investigative Site 204

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Võru : Forest Investigative Site 202

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Espoo : MSD Finland Oy

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)

Helsinki : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Helsinki : ARTES Psykiatrinen Palvelukeskus Oy

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Helsinki :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Helsinki : FI008

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Helsinki : FI002

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Helsinki : FI004

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Helsinki : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Helsinki : Forest Investigative Site 301

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Helsinki : Forest Investigative Site 304

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Helsinki : Forest Investigative Site 302

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Jarvenpaa : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Joensuu : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Kuopio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Kuopio : Satucon Oy

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Kuopio :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Kuopio : FI001

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Kuopio : Forest Investigative Site 305

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Lohja : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Oulu : FI009

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Oulu : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Oulu : Forest Investigative Site 308

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Pori : Forest Investigative Site 307

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Rauma : FI006

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Seinajoki : FI003

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Tampere : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Tampere : Satakunnan Psykiatripalveiu Oy at Mentoria Oy

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Tampere : FI005

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Tampere : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Turku : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Turku : Puutorin Psykiatripalvelu

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Turku :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Besancon : CHU Besancon - Clinical Psychaitric Department

Study of Transcranial Direct Current Stimulation (tDCS) as add-on Treatment for Resistant Major Depression

Besançon : C.H.U. Saint-Jacques - Service de Psychiatrie de l'Adulte

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Bron : C.H. Le Vinatier - EA 4166, UCB Lyon 1 - Department of Psychiatry - Service du Pr d'AMATO

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Caen : FR003

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Clermont Ferrand : C.H.U. Gabriel Montpied - Service de Psychiatrie et Psychologie Médicale - CMP A

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Colombes : Hôpital Louis Mourier

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

DAX : Research Site

Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolar Disorder

Dijon : C.H.U. Dijon, Hôpital Général - Service de Psychiatrie et d'Addictologie

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Dijon Cedex : FR008

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Dole : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Douai : FR006

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Douai : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Elancourt : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Grenoble : C.H.U. de Grenoble, Hôpital sud - Département de Psychiatrie

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Jonzac : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Lézignan-Corbières : ASM Limoux

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Lille : Hôpital Fontan - C.H.R.U. Lille

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Limoges Cedex : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Marseille : C.H. Sainte Marguerite

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Montpellier : CHU - Hôpital La Colombière

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Montpellier Cedex 5 : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Nice : Hôpital Pasteur - CHU Nice

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Paris : FR

A Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder

Paris : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Paris : Hôpital Sainte Anne - Service Hospitalo-Universitaire de Santé Mentale et de Thérapeutique

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Paris : MSD France

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)

Poitiers : C.H.U. de POITIERS

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Rennes : C.H.U. - C.H. Guillaume Régnier

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Rouen : C.H.U. Charles Nicolle - Service Hospitalo-Universitaire de Psychiatrie

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Saint-Denis : EPS de Ville Evrard - Unité de Saint-Denis

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

St Etienne cedex : CHU St Etienne - Hôpital Nord

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Tours : CPU CHRU de Tours

BDNF Gene Polymorphism and Antidepressants Treatment

Achim : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Achim : Gemeinschafstpraxis für Neurologie und Psychiatrie, Psychotherapie

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Achim : DE007

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Achim : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Achim : Teva Investigational Site 655

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Altenholz-Stift : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Aschaffenburg : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Augsburg : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Bad Honnef : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Bad Saarow : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Baesweiler : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Bayreuth : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Berlin :

A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression

Berlin : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Berlin : Private Praxis Dr. Jana Thomsen

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Berlin : Alexander Schulze, MD

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Berlin : emovis GmbH

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Berlin :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Berlin : DE005

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Berlin : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Berlin : DE002

Pharmacokinetics and Tolerability of Lu AA21004 in Child and Adolescent Patients With Depressive or Anxiety Disorder

Bielefeld : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Bochum : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Bochum : Private Practice Drs. Bitter/Schumann

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Bochum :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Bonn : University Clinic Bonn

The Effect of Duloxetine on Interoceptive Awareness

Bremerhaven : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Buchholz : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Butzbach : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Chemnitz :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Cologne : Teva Investigational Site 653

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Dortmund : Research Site

European Drug Utilization Study

Dresden : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Dresden : Teva Investigational Site 651

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Erfurt : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Essen : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Freiburg :

A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression

Freiburg : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Grevenbroich : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Haar : Merck Sharp & Dohme GmbH

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)

Hamburg : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Hannover : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Hannover :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Hannover : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Heidenheim : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Kastellaun : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Klingenmünster : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Königsbrück : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Leipzig : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Leipzig : ZSL Zentrum fuer medizinische Studien in Leipzig

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Lohr am Main : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Mainz :

A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression

Mainz : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Mainz : DE001

Pharmacokinetics and Tolerability of Lu AA21004 in Child and Adolescent Patients With Depressive or Anxiety Disorder

Mannheim : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Mannheim : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Marburg : Department of Clinical Psychology and Psychotherapy, Philipps University Marburg

End-of-Life Fear in Patients With End-Stage Lung Disease (COPD)

Merzig : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Mittweida : Teva Investigational Site 652

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Muenchen : Studienzentrum Muenchen

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Munchen :

A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression

München : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Munich : Klinik für Psychiatrie und Psychotherapie, Ludwig-Maximilians-Universität Updated

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Munich : Department of Psychiatry and Clin. Radiology, Ludwig-Maximilian-University

Somatosensory Processing in Depression

Münster : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Nienburg : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Nuernberg : Studienzentrum Klinikum Nuernberg

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Nümbrecht : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Nurnberg : DE009

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Oberhausen : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Oldenburg : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Ostfildern : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Ostfildern : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Potsdam : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Schönau am Königssee : Klinikum Berchtesgadener Land, Schön Kliniken

End-of-Life Fear in Patients With End-Stage Lung Disease (COPD)

Schwalmstadt-Treysa : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Schwerin : Somni bene GmbH

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Schwerin :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Siegen : Private Practice: Eugen Schlegel

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Sinsheim : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Stadtroda : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Stralsund : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Stuttgart : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Telgte : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Tübingen : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Weil am Rhein : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Wermsdorf : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Westerstede : Studiezentrum Nord-West

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Westerstede :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Wiesbaden :

Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder

Wiesbaden : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Wuerzburg : Medizinisches Studienzentrum Wuerzburg

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Wurzburg : DE001

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Wurzburg : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Zwickau : Novartis Investigative Site

Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression

Baja N/A :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Budapest :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Budapest : Semmelweis Univ. Dept.of Psychiatry

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Budapest : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Budapest : Teva Investigational Site 662

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Budapest : Teva Investigational Site 661

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Budapest : Teva Investigational Site 664

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Gyor : Teva Investigational Site 665

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Kalocsa :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Nagyerkei : Debrecent Egyetem Orvos es Egeszsegtudomanyl Centrum Pszichiatrai

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Nagykallo : Santha Kalman Mentalis Egeszsegkozpont es Szakkorhaz

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Nagykallo : Teva Investigational Site 666

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Nyiregyhaza : Josa Andras Teaching Hospital

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Sziget : Pecsi Tudomanyegyeiem Pszichiatriai es Pszichoterapias Klinika

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Ahmedabad : Local Institution

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Chennai : Local Institution

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Mumbai : Local Institution

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Pune : Local Institution

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Pune : Local Institution

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Varanasi : Local Institution

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Visakhapatnam : Local Institution

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Beer Yaacov : Beer Yaacov Mental Health Center Updated

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Hod Hasharon : shalvataMHC

Double Blind Randomized Controlled, H1 Coil In Subjects With Bipolar Depression

Jerusalem : Hadasah Ein-Karem Medical Center Updated

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Netanya : Lev Hasharon Updated

Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression

Tel Hashomer : Sheba Medical Center, Department of psychiatry

Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder

Catania : Teva Investigational Site 688

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Firenze : Teva Investigational Site 689

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Genova : Teva Investigational Site 686

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Milano : Azienda Ospedaliera Luigi Sacco - Polo Universitario

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Pisa : Teva Investigational Site 687

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Roma : Teva Investigational Site 692

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Adachi-ku : Suzuki Hospital

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Adachi-ku : Suzuki Hospital

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Aichi : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing

Amagasaki : Arai Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Amagasaki-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Anan-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Annaka-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Ashiya : Terauchi-Takahashi Psychiatric Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Ashiya : Terauchi-Takahashi Psychiatric Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Chiba : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Chiba : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing

Chiba : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY221668412 in Patients With Major Depression Disorder

Chiyoda-ku : Iidabashi Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Chubu :

A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Chugoku :

A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Chuo-ku : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Fujioka-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Fujisawa-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Fukaya-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Fukuoka : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Fukuoka : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Fukuoka : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing

Fukuoka : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY221668412 in Patients With Major Depression Disorder

Fukuoka : Kuranari Psychiatry Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Fukuoka : Tenjin Mental Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Fukuoka : Stress Care Yoshimura Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Fukuoka : Tenjin Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Fukuoka : Ange Psychiatric Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Fukuoka : Sugahara Tenjin Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Fukuoka : Imato Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Fukuoka : Kuranari Psychiatry Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Fukuoka : Stress Care Yoshimura Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Fukuoka : Hiro Mental Clinic Tenjinminami

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Fukuoka : Medical Corporation Shinseikai Kaku Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Fukuoka : Akasaka Kato Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Fukuoka-city :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Fukuoka-city : Hatsuki Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Fukuoka-shi : Stress Care Yoshimura Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Fukushima : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Fukushima : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Fukushima : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing

Fukushima : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY221668412 in Patients With Major Depression Disorder

Hachioji-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Hatsukaichi : Fujikawa Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Hatsukaichi : Fujikawa Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Hatsukaichi-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Hirakata : Kuginuki Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Hiroshima : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing

Hiroshima-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Hokkaido : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing

Hokkaido : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY221668412 in Patients With Major Depression Disorder

Hokkaido :

A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Hokkaido :

Long-term Study of FK949E in Elderly Bipolar Disorder Patients

Hokkaido : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Hokkaidou :

Study to Evaluate the Effect and Safety of FK949E in Major Depressive Disorder Patients

Hyogo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Hyogo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Hyogo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing

Hyogo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY221668412 in Patients With Major Depression Disorder

Ibaraki :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Inzai : Nippon Medical School Chiba Hokusoh Hospital

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Inzai : Nippon Medical School Chiba Hokusoh Hospital

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Inzai-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Kanagawa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Kanagawa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Kanagawa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing

Kanagawa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY221668412 in Patients With Major Depression Disorder

Kanagawa : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Kanazawa : National Hospital Organization Kanazawa Medical Center

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Kanazawa : National Hospital Organization Kanazawa Medical Center

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Kansai :

A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Kanto :

A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Kantou :

Study to Evaluate the Effect and Safety of FK949E in Major Depressive Disorder Patients

Katsushika-ku :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Katsushika-ku : Fuku Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Kawasaki : Medical Corporation Seishinkai Kishiro Mental Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Kawasaki : Medical Corporation Seishinkai Kishiro Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Kawasaki-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Kinki :

Study to Evaluate the Effect and Safety of FK949E in Major Depressive Disorder Patients

Kita-ku : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Kitakyushu-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Kobe : Ikeuchi Psycho Induced Internal Med.Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Kobe : Tatsuta Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Kobe : Ikeuchi Psycho Induced Internal Med.Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Kobe-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Kumamoto-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Kumamoto-shi : Yuge Hospital

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Kurashiki-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Kurayoshi-shi : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Kure : Hayakawa Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Kyoto : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Kyoto : Sagaarashiyama-Tanaka Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Kyoto : Sagaarashiyama-Tanaka Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Kyoto-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Kyushu :

A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Minato-ku : Akasaka Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Minato-ku : SAKURAZAKA CLINIC SophyAnce

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Musashino-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Nagano : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Nagano : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing

Nagano : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY221668412 in Patients With Major Depression Disorder

Nagoya : Mizuho Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Nagoya : Narumi Himawari Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Nakano-ku : Heartcare Ginga Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Nakano-Ku : Harikae mental clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Nanyo-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Nara : Kyo Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Noda City : Nakamoto Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Noda City : Nakamoto Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Noda-City :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Okayama : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing

Omuta : Shiranui Hospital

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Omuta : Shiranui Hospital

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Omuta-city : Oka Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Osaka : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing

Osaka : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Osaka : JIN clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Osakasayama-shi : Shibamoto Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Osakasayama-shi : Shibamoto Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Osaka-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Osaka-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Saga : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Saga : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY221668412 in Patients With Major Depression Disorder

Sagamihara : Yutaka Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Sagamihara : Yutaka Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Sagamihara-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Saitama : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing

Saitama : Misato Ekimae Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Saitama-city :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Saitama-city : Sakai Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Sapporo : Maruyamapark Mentalclinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Sapporo-Shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Sapporo-Shi : Kawamura Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Setagaya-ku : Sangenjaya Nakamura Mental Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Setagaya-ku : Komazawa Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Setagaya-ku : Sangenjaya Nakamura Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Shibuyaku : Yoyoginomori Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Shibuya-ku : Maynds Tower Mental Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Shibuya-ku : Maynds Tower Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Shibuya-ku : Omotesando Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Shikoku :

A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Shinagawa-ku : Meguro sta.East Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Shinagawa-Ku : Himeno Tomomi Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Shinjuku-ku : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Shinjuku-ku : Tokyo Kosei Nenkin Hospital

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Shinjuku-ku : Tokyo Women's Medical University Hospital

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Shinjuku-ku : Kagurazaka Stress Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Shinjuku-ku : Tokyo Kosei Nenkin Hospital

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Shinjuku-ku : Nishi-Shinjuku Concieria Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Shinjuku-ku : Tamaki Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Takasaki-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Tochigi : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing

Tokushisma-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Tokyo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Tokyo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Tokyo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing

Tokyo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY221668412 in Patients With Major Depression Disorder

Tokyo :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Tokyo : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Tokyo : Omotesando Mental Clinic 9F Success Aoyama

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Tokyo : Eto Mental Clinic Meguro

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Toshima-ku : Himorogi Psychiatric Institute

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Toshima-ku : Himorogi Psychiatric Institute

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Touhoku :

A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Utsunomiya-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Yokohama-shi :

Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder

Yokohama-Shi : Azamino Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Yokosuka city : Shioiri Mental Clinic

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Yokosuka city : Shioiri Mental Clinic

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Ansan : 03

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Ansan : Korea University Ansan Hospital

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Anyang : 19

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Anyang : Hallym Univesity Sacred Heart Hospital

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Bucheon : KR005

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Busan : 08

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Busan : 26

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Busan : Dong-A University Hospital

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Chungbuk : 23

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Daegu : 04

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Daegu : 05

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Daegu : Dongsan Medical Center

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Daejeon : Chungnam National University Hospital

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Daejon : 16

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Goyang : 28

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Goyang : Dongguk University International Hospital

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Goyang-si : Dongguk University International Hospital

Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients

Guri : Hanyang University Guri Hospital

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Gwangju : Chonnam National University Hospital

Escitalopram in Depressive Patients With Acute Coronary Artery Syndrome

Gwangju : 29

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Gwangju : 24

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Gwangju : Chosun University Hospital

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Gyeonggi-Do : 11

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Gyeonggi-do : Kwandong University College of Medicine Myongji Hospital

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Inchon : Inha University Hospital

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Jinju : 15

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Kangnam : Samsung Medical Center

Development of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide Scanning

Seoul : Seoul National University Hospital

Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder

Seoul : Seoul National University Hospital

Lexapro®'s Efficacy After Dose Escalation in Remission Study

Seoul : Seoul National University Hospital

Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients

Seoul : Seoul St. Mary's Hospital

Quality of Life and Depression in Dialysis Patients

Seoul : 02

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 20

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 13

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 18

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 06

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 14

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 21

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 01

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 17

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 09

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 27

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 10

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 22

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 07

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : 12

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Seoul : KR003

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Seoul : KR001

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Seoul : KR002

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Seoul : KR006

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Seoul : KR007

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Seoul : KyungHee University Medical Center

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Seoul : Asan Medical Center

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Seoul : Severance Hospital

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Seoul : Konkuk Univ. Hospital

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Sungnam : KR004

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Yangsan : 25

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Daugavpils : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Daugavpils : LV006

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Jelgava : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Jelgava : LV002

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Liepaja : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Liepaja : LV004

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Riga : LV003

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Sigulda : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Sigulda : LV005

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Strenci : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Strenci : LV001

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Aguascalientes : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Leon : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Leon Gto : MX001

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Leon Guanajuato : Hospital Aranda de la Parra Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Mazatlan : MX003

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Monterrey : Centro Regiomontano de Investigacion S.C. (CRI) Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Monterrey : MX005

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Monterrey : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Nuevo Leon : Instituto de Infromacion e Investigación en Salud Mental (INFOSAME) Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

San Luis Potosi : Consultorio Especializado en Psiquiatria Infantil y Adolescentes Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Sinaloa : B & B Investigaciones Medicas S.C. Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Monaco : Centre Hospitalier Princesse Grace

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Nijmegen : Brainclinics Diagnostics B.V.

International Study to Predict Optimised Treatment - in Depression

Auckland : University of Auckland

International Study to Predict Optimised Treatment - in Depression

Drammen : MSD Norge A/S

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)

Lorenskog : Akershus University Hospital

Depression and Cardiovascular Risk Markers: Effects of Rosuvastatin Therapy

Las Pinas : Private Clinic

Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients

Manila : Private Clinic

Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients

Pasay City : Private Clinic

Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients

?Uromin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Belchatow : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Bialystok : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Bialystok : Prywatne Gabinety Lekarskie "Promedicus"

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Bialystok : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Bialystok : Teva Investigational Site 259

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Bydgoszcz : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Bydgoszcz : NZOZ Centrum Kultury, Higieny i Zdrowia Psychicznego

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Chelmno : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Chelmno : Zespol Opieki Zdrowotnej w Chelmnie

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Choroszcz : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Gdansk : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Gdansk :

A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression

Gdansk : Centrum Badan Klinicznuch Pl-House sp. z.o.o.

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Gdansk : Klinika Chorob Psychicznych i Zaburzen Nerwicowych

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Gdansk : Teva Investigational Site 257

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Gdynia : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Gdynia : Teva Investigational Site 258

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Gorlice : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Gorlice : Centrum Psychiatrii i Psychoterapli

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Katowice : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Kielce : NZOZ Syntonia, Poradnia Zdrowia Psychicznego

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Kielce : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Krakow : Teva Investigational Site 155

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Leszno : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Lodz : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Lublin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Lublin : Osrodek Badafi Klinicznych Prof dr hab n med Meszek Szczepanski Prywatna Praktyka Lekarska

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Skorzewo : Teva Investigational Site 255

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Szczecin : Teva Investigational Site 861

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Torun : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Tuszyn : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Tuszyn : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Zuromin : Samodzielny Publiczny Zespol Zakladow Opieki Zdrowotnej w Zurominie

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Corozal : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Ponce : Local Institution

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Ponce : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

San Juan : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

San Juan : Forest Investigative Site 033

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

San Juan : Forest Investigative Site 034

An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

San Juan : Dharma Institute & Research Center Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

San Juan : INSPIRA Clinical Research Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Arad :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Arad : Spitatul Clinic Judetean de Urgenta Arad, Clinica de Psihiatrie

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Botosani : Stefi-Dent SRL

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Bucaresti : Spitalui Clinic de Psihiatrie "Prof. Dr. Alexandru Obregia" Sectia Clinica Psihiatrie I

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Bucuresti : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Constanta : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Craiova : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Iasi :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Oradea : Crucea Alba

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Targouiste : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Targoviste : Lorentina 2201 SRL

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Targu Mures : Spitalul Clinic Judetean Mures

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Targu Mures : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Arkhangelsk : Forest Investigative Site 601

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Ekaterinburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Ekaterinburg : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Lipetsk : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Moscow : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Moscow : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Moscow : Forest Investigative Site 607

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Moscow : Forest Investigative Site 611

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Moscow : Forest Investigative Site 605

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Moscow : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Nizhniy Novgorod : Forest Investigative Site 603

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Nizny Novgorod :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Rostov on Don : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Rostov-On-Don : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Saint Petersburg : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Saint-Petersburg : Forest Investigative Site 612

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Saratov :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Saratov : Forest Investigative Site 616

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

St Petersburg :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

St. Petersburg : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

St. Petersburg : Updated

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

St. Petersburg : Forest Investigative Site 602

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

St. Petersburg : Forest Investigative Site 606

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

St. Petersburg : Forest Investigative Site 615

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

St. Petersburg : Forest Investigative Site 613

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

St. Petersburg : Forest Investigative Site 608

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

St. Petersburg : Forest Investigative Site 604

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

St-Peterburg :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

St-Petersburg :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Tomsk :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Tomsk : Forest Investigative Site 609

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Voronezh : Forest Investigative Site 610

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Belgrade : RS005

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Belgrade : RS002

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Belgrade : Teva Investigational Site 177

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Nis : RS003

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Nis : Teva Investigational Site 837

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Banska Stiavnica : Forest Investigative Site 602

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Bojnice : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Bratislava : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Bratislava : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Bratislava : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Bratislava : SK001

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Bratislava : Forest Investigative Site 606

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Bratislava : Forest Investigative Site 604

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Bratislava : Teva Investigational Site 699

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Kosice : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Levice : SK007

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Liptovsky Mikulas : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Michalovce : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Michalovce : Forest Investigative Site 601

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Michalovce Stranany : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Rimavska Sobota : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Rimavska Sobota : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Rimavska Sobota : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Rimavska Sobota : SK002

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Rimavska Sobota : Forest Investigative Site 605

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Rimavska Sobota : Forest Investigative Site 607

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Rimavska Sobota : Teva Investigational Site 697

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Roznava : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of Flexible or Fixed Dose LLY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment

Roznava : Teva Investigational Site 696

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Svidnik : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Svidnik : SK003

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Svidnik : Forest Investigative Site 603

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Trencin : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Trencin : SK005

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Trencin : Teva Investigational Site 698

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Trnava : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Zlate Moravce : SK006

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Bellville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Bellville : Cape Trial Centre

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Bellville : Flexivest Fourteen Research Centre

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Bellville, Cape Town : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Bloemfontein : ZA004

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Cape Town : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Cape Town : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Cape Town : ZA001

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Cape Town : Teva Investigational Site 707

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Cape Town : Teva Investigational Site 712

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Cape Town, Western Cape : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Centurion : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Centurion : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Centurion : Vista Clinic

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Centurion : Teva Investigational Site 708

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Centurion, Pretoria : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Durban : ZA002

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

George : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

George : George Medi Clinic Extension

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Johannesburg : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Johannesburg : Private Practice - Gerta Brink

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Johannesburg : Teva Investigational Site 710

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Nieu Muckleneuk, Pretoria : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Paarl : Teva Investigational Site 711

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Port Elizabeth : ZA005

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Pretoria : Teva Investigational Site 706

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Somerset West : Somerset West Clinical Research

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Tygervalley : Research Site

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

West Cape : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Barcelona : Hospital Cl�c de Barcelona

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Barcelona : Servicio de Reumatologia,Institut Ferran de Reumatologia-Clinica CIMA

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Barcelona : Hospital de l�Esperan

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Barcelona : Instituto Universitario USP Dexeus

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Barcelona : Hospital Universitari de Bellvitge, Servicio de Psiquiatria Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Guadalajara : Hospital General Universitario de Guadalajara

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Madrid : Hospital General Universitario Gregorio Mara

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

Salamanca : Centro Salud Alamedilla Unidad de Salud Mental Updated

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Göteborg : SU/ Affektiva 1

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Halmstad : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Kungens Kurva : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Lund : ProbarE i Lund AB

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Lund : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Lund : Forest Investigative Site 803

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Malmo : Ekdahl Medical AB

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Malmo : INM Psykiatrisk Mottagning

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Malmö : Forest Investigative Site 802

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Sollentuna : MSD

Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022 AM3)

Solna : Forest Investigative Site 801

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Stockholm : Medinstructor Lippitz AB

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Uppsala : Dr. Wahlstedts mottagning

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Uppsala : Local Institution

Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

Uppsala : Forest Investigative Site 804

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Basel : University Hospital Basel

General Practice Research Database Seroquel XR Safety Study

Geneva : Centre de Thérapies Breves (CTB), Secteur Jonction

EScitalopram PIndolol ONset of Action

Douliou City : TW003

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Kaoshiung : TW004

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

New Taipei City : TW007

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Taichung : Chung Shan Medical University Hospital

Aripiprazole for the Augmentation of Antidepressant Therapy

Tainan : TW008

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Taipei : Taipei Veterans General Hospital

A Dose Escalation Phase I Study of PDC-1421 Capsule Targeting in Depression

Taipei : TW006

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Taipei : TW002

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Taipei : TW005

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Taoyuan : TW001

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Bangkok : TH002

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Chiang Mai : TH001

Study of Lu AA21004 in Major Depressive Disorder in Asian Countries

Chenigiv : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Chernihiv District : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Dnipropetrovsk : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Dnipropetrovsk : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Dnipropetrovsk : UA013

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Dnipropetrovsk : Teva Investigational Site 181

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Donetsk : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Donetsk :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Donetsk : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Donetsk : UA006

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Donetsk : Teva Investigational Site 872

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Glevakha :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Glevakha : UA003

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Kerch : Forest Investigative Site 707

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Kharkiv :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Kharkiv : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Kharkiv : UA002

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Kharkiv : Forest Investigative Site 703

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Kharkiv : Forest Investigative Site 704

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Kharkiv : Forest Investigative Site 702

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Kharkiv : Forest Investigative Site 703

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Kharkiv : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Kharkiv : Teva Investigational Site 282

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Kharkov : Forest Investigative Site 704

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Kherson : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Kherson : UA005

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Kherson : Forest Investigative Site 709

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Kiev : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Kiev :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Kiev : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Kiev : UA009

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Kiev : UA012

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Kiev : Research Site

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Kyiv : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Kyiv : Forest Investigative Site 702

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Kyiv : Forest Investigative Site 701

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Kyiv : Forest Investigative Site 701

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Kyiv : Forest Investigative Site 708

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Lugansk : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Lugansk : Teva Investigational Site 180

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Lviv : UA011

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Lviv : Teva Investigational Site 873

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Odesa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Odesa : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Odesa : Forest Investigative Site 709

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Odesa : Forest Investigative Site 710

Safety, Tolerability, and Efficacy of Cariprazine for Patients With Bipolar Depression

Odessa :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Odessa : Updated

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Odessa : Teva Investigational Site 875

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Poltava : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Updated

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Poltava : UA004

Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

Depression Clinical Trials

Alabama

Arizona

Arkansas

California

Colorado

Connecticut

Delaware

District of Columbia

Florida

Georgia

Illinois

Indiana

Kansas

Kentucky

Louisiana

Maryland

Massachusetts

Michigan

Minnesota

Mississippi

Missouri

Nebraska

Nevada

New Hampshire

New Jersey

New Mexico

New York

North Carolina

Ohio

Oklahoma

Oregon

Pennsylvania

Rhode Island

South Carolina

Tennessee

Texas

Utah

Vermont

Virginia

Washington

Wisconsin

Argentina

Australia

Austria

Belgium

Brazil

Bulgaria

Canada

Chile

China

Croatia

Czech Republic

Denmark

Estonia

Finland

France

Germany

Hungary

India

Israel

Italy

Japan

Korea, Republic of

Latvia

Mexico

Monaco

Netherlands

New Zealand

Norway

Philippines

Poland

Puerto Rico

Romania

Russian Federation

Serbia

Slovakia

South Africa

Spain

Sweden